D
Sell
2/11/2025Upgraded
Diagnamed Holdings Corp. (DMED) was upgraded to D- from E+ on 2/11/2025 due to an increase in the volatility index, growth index and valuation index. Operating cash flow increased 95.03% from -$153 to -$7.6, EBIT increased 25.66% from -$114.2 to -$84.9, and earnings per share increased from -$0.002 to -$0.0018.
E
Sell
2/7/2025Downgrade
Diagnamed Holdings Corp. (DMED) was downgraded to E+ from D- on 2/7/2025 due to a decline in the volatility index.
D
Sell
11/13/2024Upgraded
Diagnamed Holdings Corp. (DMED) was upgraded to D- from E+ on 11/13/2024 due to an increase in the volatility index and total return index.
E
Sell
10/17/2024Downgrade
Diagnamed Holdings Corp. (DMED) was downgraded to E+ from D- on 10/17/2024 due to a decline in the volatility index and total return index.
D
Sell
10/2/2024Upgraded
Diagnamed Holdings Corp. (DMED) was upgraded to D- from E+ on 10/2/2024 due to an increase in the total return index and volatility index.
E
Sell
9/16/2024Downgrade
Diagnamed Holdings Corp. (DMED) was downgraded to E+ from D- on 9/16/2024 due to a decline in the total return index and volatility index.
D
Sell
8/30/2024Upgraded
Diagnamed Holdings Corp. (DMED) was upgraded to D- from E+ on 8/30/2024 due to a large increase in the growth index and valuation index. EBIT increased 39.26% from -$188 to -$114.2.
E
Sell
8/1/2023Upgraded
Diagnamed Holdings Corp. (DMED) was upgraded to E+ from E on 8/1/2023 due to an increase in the growth index.
E
Sell
6/2/2023None
Diagnamed Holdings Corp. (DMED) was downgraded to E from U on 06/02/2023.
